Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

SELL
$209.01 - $232.56 $117,254 - $130,466
-561 Reduced 71.46%
224 $48,000
Q4 2023

Jan 11, 2024

BUY
$197.69 - $227.29 $142,336 - $163,648
720 Added 1107.69%
785 $178,000
Q1 2022

Apr 29, 2022

SELL
$259.82 - $298.18 $6,495 - $7,454
-25 Reduced 27.78%
65 $17,000
Q4 2020

Jan 29, 2021

BUY
$186.91 - $214.42 $12,149 - $13,937
65 Added 260.0%
90 $18,000
Q2 2020

Jul 10, 2020

SELL
$113.31 - $182.44 $339 - $547
-3 Reduced 10.71%
25 $4,000
Q1 2019

Apr 29, 2019

BUY
$123.7 - $156.3 $371 - $468
3 Added 12.0%
28 $4,000
Q2 2018

Jul 27, 2018

BUY
$160.33 - $189.41 $4,008 - $4,735
25 New
25 $4,000
Q2 2018

Jul 20, 2018

SELL
$160.33 - $189.41 $4,008 - $4,735
-25 Closed
0 $0
Q3 2017

Oct 23, 2017

BUY
$149.47 - $160.56 $3,736 - $4,014
25
25 $4,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.